|
ZNF28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.040100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.239820E-02 |
| Normal-vs-Stage2 |
4.178200E-03 |
| Normal-vs-Stage3 |
2.845100E-04 |
| Normal-vs-Stage4 |
2.17349999999117E-05 |
| Stage1-vs-Stage2 |
2.052000E-01 |
| Stage1-vs-Stage3 |
2.484400E-02 |
| Stage1-vs-Stage4 |
2.796600E-03 |
| Stage2-vs-Stage3 |
6.171800E-01 |
| Stage2-vs-Stage4 |
2.712800E-01 |
| Stage3-vs-Stage4 |
5.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.607200E-04 |
| Normal-vs-AfricanAmerican |
6.03719999991981E-07 |
| Normal-vs-Asian |
7.982000E-01 |
| Caucasian-vs-AfricanAmerican |
2.620000E-03 |
| Caucasian-vs-Asian |
3.556800E-01 |
| AfricanAmerican-vs-Asian |
3.228200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.844460E-03 |
| Normal-vs-Female |
6.10319999999609E-05 |
| Male-vs-Female |
2.752000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.022300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.157600E-03 |
| Normal-vs-Age(61-80Yrs) |
6.772600E-04 |
| Normal-vs-Age(81-100Yrs) |
6.611000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.369980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.831800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.457200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.222400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.343500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.404200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.835000E-01 |
| Normal-vs-Grade 2 |
1.782140E-02 |
| Normal-vs-Grade 3 |
5.793000E-04 |
| Normal-vs-Grade 4 |
8.04249999930562E-08 |
| Grade 1-vs-Grade 2 |
9.192600E-01 |
| Grade 1-vs-Grade 3 |
4.958800E-01 |
| Grade 1-vs-Grade 4 |
3.520400E-02 |
| Grade 2-vs-Grade 3 |
9.496300E-02 |
| Grade 2-vs-Grade 4 |
2.34739999999123E-05 |
| Grade 3-vs-Grade 4 |
3.599000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.399220E-01 |
| Normal-vs-ccB subtype |
1.078580E-03 |
| ccA subtype-vs-ccB subtype |
3.783900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.215290E-03 |
| Normal-vs-N1 |
1.033770E-01 |
| N0-vs-N1 |
5.936000E-01 |
|
|
